SelectScience
Join Free
Accelerating Science
NewsDrug discovery > Lead Discovery

Virtual Biopharmaceutical Summit 2020: Full meeting agenda

SelectScience

Watch world-leading scientists and industry experts present the latest advances and emerging trends in biopharma, online December 8-10

27 Nov 2020
Tom Casburn
Associate Editor

Editorial article

SelectScience Virtual Analytical Summit 2020 logo
Reserve your place today and join us online from December 8-10, 2020

The full exciting schedule has been announced for the inaugural SelectScience® Virtual Biopharmaceutical Summit, taking place from December 8-10.

Free Registration

Covering the latest developments in biopharmaceuticals, from gene therapy to nanomedicines, drug discovery, LC method development, personalized vaccines and more, this groundbreaking online event will feature talks by an outstanding lineup of world-leading speakers and top manufacturers, as well as live Q&As, virtual resource hubs and dedicated networking sessions – all completely free of charge.

Dr. Lewis Francis, a keynote speaker at the recent Virtual Biopharmaceutical Summit, highlighted the significance of these virtual events, commenting: “Taking the opportunity to share our work with a global audience is an important part of what we do, getting feedback and input from worldwide audiences and disseminating our cutting-edge approaches to develop with the wider scientific and biopharmaceutical community."

Register now to reserve your free place and read on to learn more about:

Keynote Speakers

Dr. Mimi Roy - Biopharma 2020 speaker

Dr. Mimi Roy

BioMarin Pharmaceutical Inc.

Strategic process and analytical development for AAV gene therapy

Dr. Jamie Moroco - Biopharma 2020 speaker

Dr. Jamie Moroco

The Broad Institute, Cambridge, MA

Enabling early drug discovery efforts with intact protein mass analysis

Dr. Lewis Francis - Biopharma 2020 speaker

Dr. Lewis Francis

University of Swansea

Nanomedicines and advanced therapeutics for gynecological cancers

Tuesday, December 8

Targeting protein-protein interactions of receptor complexes
Prof. Kristian Strømgaard, University of Copenhagen
13:00 (GMT) / 14:00 (CET) / 08:00 (EST) / 05:00 (PST)
Add to Calendar

Accelerating workflows for calprotectin and complement (C4d, TCC) biomarker assays with nanoliter-scale microfluidic immunoassays
Gyros Protein Technologies
13:45 (GMT) / 14:45 (CET) / 08:45 (EST) / 05:45 (PST)
Add to Calendar

Synthesis and characterization of antibody-drug conjugates
Malvern Panalytical - Dr. Jamie Stokes, Principal Research Scientist, Concept Life Sciences
14:30 (GMT) / 15:30 (CET) / 09:30 (EST) / 06:30 (PST)
Add to Calendar

Networking Session: Next-gen technologies for gene therapy
SelectScience - Corning Life Sciences
15:15 (GMT) / 16:15 (CET) / 10:15 (EST) / 07:15 (PST)
Add to Calendar

Remote cell confluence monitoring with the Corning® StackSENSE™ System
Corning Life Sciences - Jamie N. Clark, Product Line Manager, Bioprocess
16:00 (GMT) / 17:00 (CET) / 11:00 (EST) / 08:00 (PST)
Add to Calendar

Implementing systematic approaches and new technology for chromatography method development
Dr. Pankaj Aggarwal, Principal Scientist, Pfizer
16:45 (GMT) / 17:45 (CET) / 11:45 (EST) / 08:45 (PST)
Add to Calendar

Scale up your cell culture and the changing landscape of ultra-low freezers
PHCbi
17:30 (GMT) / 18:30 (CET) / 12:30 (EST) / 09:30 (PST)
Add to Calendar

Strategic process and analytical development for AAV gene therapy
Keynote: Dr. Mimi Roy, Senior Director of Analytical Chemistry, BioMarin Pharmaceutical Inc.
18:15 (GMT) / 19:15 (CET) / 13:15 (EST) / 10:15 (PST)
Add to Calendar

Glycosylation and sialic acid analysis of biotherapeutic glycoproteins
Agilent Technologies - Tom Rice, Product Manager, Bioconsumables
19:00 (GMT) / 20:00 (CET) / 14:00 (EST) / 11:00 (PST)
Add to Calendar

Wednesday, December 9

Machine learning applications for the characterization of particle profiles of therapeutic products
Dr. Amber Fradkin, Director, Particle Characterization Core Facility, KBI Biopharma
13:00 (GMT) / 14:00 (CET) / 08:00 (EST) / 05:00 (PST)
Add to Calendar

Purity and identity characterization of adeno-associated virus capsid particles by intact and bottom-up based LC-MS
Agilent Technologies - Chris Colangelo, Biopharma Market Specialist
13:45 (GMT) / 14:45 (CET) / 08:45 (EST) / 05:45 (PST)
Add to Calendar

Getting to know your protein: An overview of FUJIFILM Diosynth Biotechnologies Analytical Development
Bio-techne - Katherine Hamilton, Senior Research Scientist, FUJIFILM Diosynth Biotechnologies
14:30 (GMT) / 15:30 (CET) / 09:30 (EST) / 06:30 (PST)
Add to Calendar

Delving deeper into AAV attributes: Enhanced characterization using multiple technologies
Malvern Panalytical - Dr. John Stenson, Product Manager
15:15 (GMT) / 16:15 (CET) / 10:15 (EST) / 07:15 (PST)
Add to Calendar

Enabling technology for cell & gene therapy
Corning Life Sciences - Dr. Keith R. Olson, Vice President, Corning Life Sciences Strategy & Technology
This presentation will now take place on Thursday, December 10
Add to Calendar

Networking Session: How could LC-MS meet emerging technology trends
SelectScience - Waters
16:45 (GMT) / 17:45 (CET) / 11:45 (EST) / 08:45 (PST)
Add to Calendar

Enabling early drug discovery efforts with intact protein mass analysis
Keynote: Dr. Jamie Moroco, Broad Institute, Center for the Development of Therapeutics
17:30 (GMT) / 18:30 (CET) / 12:30 (EST) / 09:30 (PST)
Add to Calendar

Advancing cancer vaccines with new research and developments
Sartorius - David E. Avigan, M.D., and Mary L. (Nora) Disis, M.D.
18:15 (GMT) / 19:15 (CET) / 13:15 (EST) / 10:15 (PST)
Add to Calendar

Glycosylation and sialic acid analysis of biotherapeutic glycoproteins
Agilent Technologies - Tom Rice, Product Manager, Bioconsumables
19:00 (GMT) / 20:00 (CET) / 14:00 (EST) / 11:00 (PST)

Current cell and gene therapy manufacturing methods
Prof. Gerhard Bauer, UC Davis Institute
19:45 (GMT) / 20:45 (CET) / 14:45 (EST) / 11:45 (PST)

Thursday, December 10

Monitoring allosteric interactions at CXCR4 using NanoBiT conjugated nanobodies
Dr. Mark Soave, The University of Nottingham
13:00 (GMT) / 14:00 (CET) / 08:00 (EST) / 05:00 (PST)
Add to Calendar

Bringing your analysis to the enterprise: Introducing Byosphere™
Protein Metrics - Dr. Eric Carlson, President & CEO
13:45 (GMT) / 14:45 (CET) / 08:45 (EST) / 05:45 (PST)
Add to Calendar

Integrated imaging and analysis to understand the biological complexity of tissues
Fluidigm - Stephanie Ling, Associate Principal Scientist, AstraZeneca
14:30 (GMT) / 15:30 (CET) / 09:30 (EST) / 06:30 (PST)
Add to Calendar

Dismantling SARS-CoV-2 one analysis at a time
Sartorius - Dr. Tabb Sullivan, Senior Scientist, and Rachel Fong, Alliance Manager, Integral Molecular
15:15 (GMT) / 16:15 (CET) / 10:15 (EST) / 07:15 (PST)
Add to Calendar

Nanomedicines and advanced therapeutics for gynecological cancers
Keynote: Dr. Lewis Francis, University of Swansea
16:00 (GMT) / 17:00 (CET) / 11:00 (EST) / 08:00 (PST)
Add to Calendar

Redefine bioprocess analytics with at-line spent media and rapid charge variant analysis
908 Devices
16:45 (GMT) / 17:45 (CET) / 11:45 (EST) / 08:45 (PST)
Add to Calendar

Cell cultivation for biopharmaceutical and biotherapeutic workflows with nature’s GEMs
MicroGEM
17:30 (GMT) / 18:30 (CET) / 12:30 (EST) / 09:30 (PST)
Add to Calendar

Enabling technology for cell & gene therapy
Corning Life Sciences - Dr. Keith R. Olson, Vice President, Corning Life Sciences Strategy & Technology
18:15 (GMT) / 19:15 (CET) / 13:15 (EST) / 10:15 (PST)
Add to Calendar

RNA therapeutic discovery using RNA-seq data
Dr. Martin Akerman, CTO & Cofounder, Envisagenics
19:00 (GMT) / 20:00 (CET) / 14:00 (EST) / 11:00 (PST)
Add to Calendar

Networking Session: Nanopharmaceuticals – challenges and opportunities
SelectScience
19:45 (GMT) / 20:45 (CET) / 14:45 (EST) / 11:45 (PST)
Add to Calendar

Sponsors

 

Register for free to reserve a place today — you’ll be able to drop in and out as you wish during the Summit.

Watch this space for further updates and follow our social media channels:

Catch up on the latest techniques and technologies and play your part in improving science communication by leaving a lab product review for a chance to win a $400 Amazon Gift Card.

Spread the word using #BiopharmaSummit

Links

SelectScienceCompany website

Tags

Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Particle CharacterizationParticle characterization instruments are used to determine particle size distribution, shape, surface area, zeta potential, density and porosity of particles and materials. Multiple tecchniques are available for determining particle size, shape and count including dynamic light scattering (DLS), laser diffraction, electrozone (Coulter technique), imaging particle analysis and single particle optical sensing. Determine the density of your material with a gas pycnometer or examine its surface area and porosity with gas adsorption analyzers and mercury porosimeters. Find the best particle characterization instruments in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Personalized medicinePersonalized medicine refers to the idea of customized healthcare, where medical decisions and treatments are tailored to the individual patient. Molecular diagnostics, companion diagnostics and Next Generation Sequencing (NGS) play a pivotal role in this approach.BiopharmaceuticalsBiopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.Cell TherapyCell therapy involves using living cells to treat diseases, often by replacing damaged cells or stimulating regeneration. Stem cell therapy and CAR-T cell therapy are examples of cutting-edge treatments in regenerative medicine and cancer immunotherapy. Browse our peer-reviewed product directory to find the best cell therapy tools, compare products, check reviews, and get pricing directly from manufacturers.Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.RNA-SeqRNA sequencing (RNA-seq) is a next-generation sequencing technique used to analyze the transcriptome, providing insights into gene expression and regulation. This method is essential for genomics, disease research, and personalized medicine. Explore RNA-seq tools in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Gene TherapyGene therapy is a technique that modifies or replaces genes within an individual's cells to treat or prevent diseases. This approach holds potential for curing genetic disorders, cancers, and certain viral infections. Advances in gene editing technologies like CRISPR are driving the growth of gene therapy. Explore gene therapy tools and technologies in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.Covid-19COVID-19, caused by the SARS-CoV-2 virus, has led to a global health crisis with profound impacts on societies and economies. Research into diagnostics, vaccines, treatments, and understanding viral mechanisms continues to evolve. The pandemic has accelerated innovations in healthcare and biopharmaceuticals, including novel vaccine platforms and rapid testing technologies. Browse our peer-reviewed product directory to find top COVID-19 testing kits, research tools, vaccines, and treatments, compare products, read reviews, and receive direct pricing from manufacturers.LC-MSLiquid Chromatography-Mass Spectrometry (LCMS) is a powerful analytical technique that combines the separation power of liquid chromatography with the detection capabilities of mass spectrometry. It is widely used for qualitative and quantitative analysis of complex mixtures in pharmaceuticals, proteomics, and environmental studies. Browse our peer-reviewed product directory to find the best LCMS systems, compare products, check reviews, and get pricing directly from manufacturers.CAR-T cell therapy

Related articles